Recent Articles

Eye Movement Desensitization and Reprocessing Treatment for Oncological Patients. Preliminary Research Project.

PDF FullText DOI: 10.52338/tejoc.2024.1005

Multiple Myeloma’s Molecular Cytogenetics.

PDF FullText DOI: 10.52338/tejoc.2024.1003

Case Study: What Is the Risk of T-Cell NHL for a Woman Who Has Had HTLV-1 Since 1998?

PDF FullText DOI: 10.52338/tejoc.2024.1002

MicroRNAs as New Tumor Biomarkers and Protein-Coding Genes of the Cancer-Related Genomic Locus 19q13.

PDF FullText DOI: 10.52338/tejoc.2024.1001

Journal Info

  • Journal Name: The European Journal of Cancer
  • Impact Factor: 2.0
  • ISSN: 3064-6731
  • DOI: 10.52338/tejoc
  • Short Name: TEJOC
  • Acceptance rate: 55%
  • Volume: 7 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days
  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility